Annual Long Term Debt
$225.70 M
+$29.22 M+14.87%
31 December 2023
Summary:
Xeris Biopharma Holdings annual long term debt is currently $225.70 million, with the most recent change of +$29.22 million (+14.87%) on 31 December 2023. During the last 3 years, it has risen by +$138.68 million (+159.36%). XERS annual long term debt is now at all-time high.XERS Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$249.87 M
-$14.63 M-5.53%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly long term debt is currently $249.87 million, with the most recent change of -$14.63 million (-5.53%) on 30 September 2024. Over the past year, it has increased by +$24.29 million (+10.77%). XERS quarterly long term debt is now -97.01% below its all-time high of $8.37 billion, reached on 31 December 2017.XERS Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.9% | +10.8% |
| 3 y3 years | +159.4% | +184.9% |
| 5 y5 years | +607.7% | +329.9% |
XERS Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +159.4% | -5.5% | +184.9% |
| 5 y | 5 years | at high | +607.7% | -5.5% | +329.9% |
| alltime | all time | at high | +607.7% | -97.0% | +1284.2% |
Xeris Biopharma Holdings Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $249.87 M(-5.5%) |
| June 2024 | - | $264.50 M(+0.2%) |
| Mar 2024 | - | $264.07 M(+17.0%) |
| Dec 2023 | $225.70 M(+14.9%) | $225.70 M(+0.1%) |
| Sept 2023 | - | $225.58 M(+1.1%) |
| June 2023 | - | $223.05 M(+13.2%) |
| Mar 2023 | - | $196.97 M(+0.3%) |
| Dec 2022 | $196.48 M(+123.1%) | $196.48 M(+41.9%) |
| Sept 2022 | - | $138.51 M(+0.3%) |
| June 2022 | - | $138.07 M(+0.3%) |
| Mar 2022 | - | $137.64 M(+56.3%) |
| Dec 2021 | $88.07 M | $88.07 M(+0.4%) |
| Sept 2021 | - | $87.71 M(+0.3%) |
| June 2021 | - | $87.48 M(+0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $87.27 M(+0.3%) |
| Dec 2020 | $87.02 M(+49.3%) | $87.02 M(-27.1%) |
| Sept 2020 | - | $119.39 M(+9.1%) |
| June 2020 | - | $109.48 M(+87.2%) |
| Mar 2020 | - | $58.48 M(+0.3%) |
| Dec 2019 | $58.30 M(+82.8%) | $58.30 M(+0.3%) |
| Sept 2019 | - | $58.12 M(+97.7%) |
| June 2019 | - | $29.40 M(-8.5%) |
| Mar 2019 | - | $32.14 M(+0.8%) |
| Dec 2018 | $31.89 M | $31.89 M(+0.8%) |
| Sept 2018 | - | $31.64 M(+74.2%) |
| June 2018 | - | $18.17 M(+0.6%) |
| Mar 2018 | - | $18.05 M(-99.8%) |
| Dec 2017 | - | $8.37 B |
FAQ
- What is Xeris Biopharma Holdings annual long term debt?
- What is the all time high annual long term debt for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual long term debt year-on-year change?
- What is Xeris Biopharma Holdings quarterly long term debt?
- What is the all time high quarterly long term debt for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly long term debt year-on-year change?
What is Xeris Biopharma Holdings annual long term debt?
The current annual long term debt of XERS is $225.70 M
What is the all time high annual long term debt for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual long term debt is $225.70 M
What is Xeris Biopharma Holdings annual long term debt year-on-year change?
Over the past year, XERS annual long term debt has changed by +$29.22 M (+14.87%)
What is Xeris Biopharma Holdings quarterly long term debt?
The current quarterly long term debt of XERS is $249.87 M
What is the all time high quarterly long term debt for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly long term debt is $8.37 B
What is Xeris Biopharma Holdings quarterly long term debt year-on-year change?
Over the past year, XERS quarterly long term debt has changed by +$24.29 M (+10.77%)